Wall Street analyst estimates for BGM Group Ltd. (BGM): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Operating from Chengdu, People's Republic of China, BGM Group Ltd. engages in the manufacturing and supply of active pharmaceutical ingredients (APIs), traditional Chinese medicine (TCM) derivatives, and various other related products across China.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-03-16 | |||
| 2024-05-15 | $0.05 |
Valuation Ratios
| Price / Book | 0.15 |
| EV / EBITDA | -9.61 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.5M | $50.4M | $46.1M | $50.0M | $57.1M | $64.9M | $46.5M | $25.1M | $37.9M |
| Cost of Revenue | $19.2M | $42.2M | $36.4M | $42.5M | $51.5M | $58.6M | $44.7M | $21.0M | $33.1M |
| Gross Profit | $3.4M | $8.1M | $9.7M | $7.5M | $5.6M | $6.2M | $1.8M | $4.1M | $4.8M |
| Research & Development | 0 | 0 | 0 | 0 | 0 | $1.2M | $568,470 | $1.4M | $672,669 |
| Selling, General & Admin | $2.3M | $2.2M | $3.5M | $2.7M | $3.3M | $2.9M | $3.8M | $3.3M | $16.8M |
| Operating Expenses | $2.3M | $2.2M | $3.5M | $2.7M | $3.3M | $4.1M | $4.4M | $4.7M | $17.4M |
| Operating Income | $1.1M | $6.0M | $6.2M | $4.8M | $2.4M | $2.1M | -$2.6M | -$563,771 | -$12.6M |
| EBITDA | $3.4M | $7.6M | $8.4M | $7.2M | $4.2M | $3.7M | -$1.3M | $879,873 | -$11.1M |
| Interest Expense | $282,842 | $216,187 | $223,657 | $242,877 | $57,671 | 0 | 0 | $639,511 | 0 |
| Pre-tax Income | $1.9M | $6.1M | $6.9M | $5.8M | $3.4M | $1.6M | -$7.9M | -$2.1M | -$19.9M |
| Income Tax | $321,458 | $943,363 | $1.0M | $864,908 | $255,133 | $194,302 | $219,166 | -$619,981 | $277,790 |
| Net Income | $1.4M | $5.2M | $5.3M | $5.1M | $3.2M | $1.1M | -$7.8M | -$1.4M | -$19.9M |
| EPS | $6.00 | $22.20 | $22.80 | $21.60 | $13.50 | $4.50 | $-32.40 | $-6.00 | $-5.40 |
| EPS (Diluted) | $6.00 | $22.20 | $22.80 | $21.60 | $13.50 | $4.50 | $-32.40 | $-6.00 | $-5.40 |
| Shares Outstanding (Diluted) | $233,333 | $233,333 | $233,333 | $233,333 | $227,262 | $240,883 | $240,883 | $240,883 | $3.8M |
Price
| Price | $9.35 |
| Market Cap | $119M |
| Exchange | NASDAQ |
| Country | CN |
Related companies: ANIP · AVDL · CLOV · EWTX · GPCR · MESO · PAHC
Explore sector: Healthcare · Drug Manufacturers - Specialty & Generic
More sections of BGM: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks